Safety and Efficacy of Intravesical Botulinum Toxin in TC-3 Gel in OAB Patients

NCT02179099 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
3
Enrollment
INDUSTRY
Sponsor class

Stopped Decision to open a randomized controlled trial with two groups receiving different Botulinum Toxin in comparison to placebo group.

Conditions

Interventions

Sponsor

UroGen Pharma Ltd.